Clinical Trials Logo

Clinical Trial Summary

Autoimmune polyendocrine syndrome (APS) is an autoimmune disease involving at least two endocrine organ. It is classified into type I and type II diseases. Among them, APS type II is more common. It is diagnosed when two of the three following diseases are diagnosed in the same patient, including type 1 diabetes mellitus, autoimmune thyroid disease, and primary adrenal insufficiency. In this study, we will observe the epidemiology, clinical characteristics, and genetic variants of APS II in Taiwan.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05578105
Study type Observational
Source National Taiwan University Hospital
Contact Shyang-Rong Shih, MD, PhD
Phone +886-972653337
Email srshih@ntu.edu.tw
Status Recruiting
Phase
Start date January 1, 2022
Completion date December 31, 2026